NovaSterilis

NovaSterilis

医疗设备制造业

Lansing,NY 868 位关注者

Providing novel supercritical CO2 solutions that help our partners create safe, innovative products that improve lives.

关于我们

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis' scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damaging the product's structural or chemical integrity. NovaSterilis serves a variety of markets, including complex medical devices, drug delivery, tissue engineering, biotherapeutics/API, and additive manufacturing. With NovaSterilis, you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

网站
https://www.novasterilis.com
所属行业
医疗设备制造业
规模
2-10 人
总部
Lansing,NY
类型
私人持股
创立
2000
领域
Decellularization、Terminal Sterilization、Supercritical Carbon Dioxide、Allografts、Xenografts、Donor Tissue、ECM、Pericardium、R&D Equipment、CRO、Biomaterials、Pressure Vessel、Process Validation、Microbiology Testing、Material Compatability、Cannabis Sterilization、Endoscope Sterilization、Tissue Banking、Supercritical Fluids和Carbon Dioxide

地点

NovaSterilis员工

动态

相似主页

查看职位